Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Congenica Selected by Genomics England to Provide Clinical Interpretation Services
Wednesday, June 03, 2015
As the 100,000 Genomes Project moves into Phase 3 Congenica has been named as a platform provider.

Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement
Tuesday, June 02, 2015
Agreement to advance miRNA and mesenchymal stem/stromal cell (MSC) regenerative technology.

Sysmex and LabCorp Announce a Strategic Collaboration
Tuesday, June 02, 2015
Collaboration for blood-based molecular testing services and products to support the development of precision medicine in oncology.

AstraZeneca, Lilly to Study Immuno-Oncology Combination
Monday, June 01, 2015
This collaboration sets out to assess the efficacy of a combinatorial treatment in patients with advanced solid state tumors.

Melanoma Drug-Resistance Mechanism Identified and Circumvented
Monday, June 01, 2015
Researchers have discovered an effective approach to improve the clinical outcome of patients with BRAF inhibitor resistant tumors.

Sequence, Shuffle, Repeat
Monday, June 01, 2015
Researchers identify origin of chromosomal oddity in some cancer cells.

Thermo's NGS Platform Selected for Nationwide Clinical Research Program
Monday, June 01, 2015
National Cancer Institute-MATCH trial to sequence thousands of tumor samples using Ion Torrent targeted sequencing technology.

Diagnosing Cancer with Help from Bacteria
Friday, May 29, 2015
Engineered probiotics can detect tumors in the liver.

Five Prime, Bluebird Bio Launch $131.5M+ Collaboration
Friday, May 29, 2015
Five Prime Therapeutics will provide exclusive rights to its human antibodies to bluebird bio under a collaboration by the companies to research, develop, and commercialize chimeric antigen receptor (CAR) T cell cancer therapies.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 3488
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters